Literature DB >> 33095384

Cancer stem cells and strategies for targeted drug delivery.

Jin Cao1,2, Shubhmita Bhatnagar2,3, Jiawei Wang2,4, Xueyong Qi1, Swayam Prabha2,5, Jayanth Panyam6,7.   

Abstract

Cancer stem cells (CSCs) are a small proportion of cancer cells with high tumorigenic activity, self-renewal ability, and multilineage differentiation potential. Standard anti-tumor therapies including conventional chemotherapy, radiation therapy, and molecularly targeted therapies are not effective against CSCs, and often lead to enrichment of CSCs that can result in tumor relapse. Therefore, it is hypothesized that targeting CSCs is key to increasing the efficacy of cancer therapies. In this review, CSC properties including CSC markers, their role in tumor growth, invasiveness, metastasis, and drug resistance, as well as CSC microenvironment are discussed. Further, CSC-targeted strategies including the use of targeted drug delivery systems are examined.
© 2020. Controlled Release Society.

Entities:  

Keywords:  Anti-tumor therapy; Cancer biology; Cancer stem cells (CSCs); Drug delivery system; Drug-resistance

Mesh:

Substances:

Year:  2020        PMID: 33095384      PMCID: PMC8062588          DOI: 10.1007/s13346-020-00863-9

Source DB:  PubMed          Journal:  Drug Deliv Transl Res        ISSN: 2190-393X            Impact factor:   5.671


  328 in total

1.  The interleukin-3 receptor alpha chain is a unique marker for human acute myelogenous leukemia stem cells.

Authors:  C T Jordan; D Upchurch; S J Szilvassy; M L Guzman; D S Howard; A L Pettigrew; T Meyerrose; R Rossi; B Grimes; D A Rizzieri; S M Luger; G L Phillips
Journal:  Leukemia       Date:  2000-10       Impact factor: 11.528

Review 2.  Targeting Notch to target cancer stem cells.

Authors:  Antonio Pannuti; Kimberly Foreman; Paola Rizzo; Clodia Osipo; Todd Golde; Barbara Osborne; Lucio Miele
Journal:  Clin Cancer Res       Date:  2010-06-08       Impact factor: 12.531

3.  Nucleus-targeted nano delivery system eradicates cancer stem cells by combined thermotherapy and hypoxia-activated chemotherapy.

Authors:  Hongjuan Li; Weixiao Yan; Xiaomin Suo; Haotong Peng; Xinjian Yang; Zhenhua Li; Jinchao Zhang; Dandan Liu
Journal:  Biomaterials       Date:  2019-02-06       Impact factor: 12.479

4.  A spermine-conjugated lipophilic Pt(iv) prodrug designed to eliminate cancer stem cells in ovarian cancer.

Authors:  Morgan Stilgenbauer; Amarasooriya M D S Jayawardhana; Payel Datta; Zhizhou Yue; Michael Gray; Frederick Nielsen; David J Bowers; Haihua Xiao; Yao-Rong Zheng
Journal:  Chem Commun (Camb)       Date:  2019-05-09       Impact factor: 6.222

Review 5.  Autophagy in cancer stem/progenitor cells.

Authors:  Yi-Hui Lin; Yu-Chun Huang; Li-Hsin Chen; Pei-Ming Chu
Journal:  Cancer Chemother Pharmacol       Date:  2014-11-26       Impact factor: 3.333

6.  Targeted Therapy for Breast Cancer Stem Cells by Liposomal Delivery of siRNA against Fibronectin EDB.

Authors:  Yujin Sun; Hoe Suk Kim; Phei Er Saw; Sangyong Jon; Woo Kyung Moon
Journal:  Adv Healthc Mater       Date:  2015-06-11       Impact factor: 9.933

Review 7.  Deadly teamwork: neural cancer stem cells and the tumor microenvironment.

Authors:  Justin D Lathia; John M Heddleston; Monica Venere; Jeremy N Rich
Journal:  Cell Stem Cell       Date:  2011-05-06       Impact factor: 24.633

8.  BCL-2 inhibition targets oxidative phosphorylation and selectively eradicates quiescent human leukemia stem cells.

Authors:  Eleni D Lagadinou; Alexander Sach; Kevin Callahan; Randall M Rossi; Sarah J Neering; Mohammad Minhajuddin; John M Ashton; Shanshan Pei; Valerie Grose; Kristen M O'Dwyer; Jane L Liesveld; Paul S Brookes; Michael W Becker; Craig T Jordan
Journal:  Cell Stem Cell       Date:  2013-01-17       Impact factor: 24.633

9.  Adoptive T-cell therapy of prostate cancer targeting the cancer stem cell antigen EpCAM.

Authors:  Zhenling Deng; Yanhong Wu; Wenbo Ma; Shuren Zhang; Yu-Qian Zhang
Journal:  BMC Immunol       Date:  2015-01-31       Impact factor: 3.615

10.  CD271 regulates the proliferation and motility of hypopharyngeal cancer cells.

Authors:  Mai Mochizuki; Keiichi Tamai; Takayuki Imai; Sayuri Sugawara; Naoko Ogama; Mao Nakamura; Kazuto Matsuura; Kazunori Yamaguchi; Kennichi Satoh; Ikuro Sato; Hozumi Motohashi; Kazuo Sugamura; Nobuyuki Tanaka
Journal:  Sci Rep       Date:  2016-07-29       Impact factor: 4.379

View more
  1 in total

Review 1.  Targeting Cancer Stem Cells by Dietary Agents: An Important Therapeutic Strategy against Human Malignancies.

Authors:  Mahshid Deldar Abad Paskeh; Shafagh Asadi; Amirhossein Zabolian; Hossein Saleki; Mohammad Amin Khoshbakht; Sina Sabet; Mohamad Javad Naghdi; Mehrdad Hashemi; Kiavash Hushmandi; Milad Ashrafizadeh; Sepideh Mirzaei; Ali Zarrabi; Gautam Sethi
Journal:  Int J Mol Sci       Date:  2021-10-28       Impact factor: 5.923

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.